Marketable Securities, Current in USD of ImmunityBio, Inc. from Q4 2015 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of investment in marketable security, classified as current.
Summary
ImmunityBio, Inc. quarterly Marketable Securities, Current history and change rate from Q4 2015 to Q3 2025.
  • ImmunityBio, Inc. Marketable Securities, Current for the quarter ending 30 Sep 2025 was $197,572,000, a 974% increase year-over-year.
Source SEC data
View on sec.gov
Marketable Securities, Current, Quarterly (USD)
Marketable Securities, Current, YoY Quarterly Change (%)

ImmunityBio, Inc. Quarterly Marketable Securities, Current (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $197,572,000 +$179,171,000 +974% 30 Sep 2025 10-Q 05 Nov 2025 2025 Q3
Q2 2025 $16,000,000 -$71,875,000 -82% 30 Jun 2025 10-Q 05 Aug 2025 2025 Q2
Q1 2025 $931,000 -$36,529,000 -98% 31 Mar 2025 10-Q 12 May 2025 2025 Q1
Q4 2024 $6,381,000 +$5,372,000 +532% 31 Dec 2024 10-Q 05 Nov 2025 2025 Q3
Q3 2024 $18,401,000 +$6,568,000 +56% 30 Sep 2024 10-Q 12 Nov 2024 2024 Q3
Q2 2024 $87,875,000 +$85,427,000 +3490% 30 Jun 2024 10-Q 12 Aug 2024 2024 Q2
Q1 2024 $37,460,000 +$34,673,000 +1244% 31 Mar 2024 10-Q 09 May 2024 2024 Q1
Q4 2023 $1,009,000 -$1,534,000 -60% 31 Dec 2023 10-K 03 Mar 2025 2024 FY
Q3 2023 $11,833,000 +$4,937,000 +72% 30 Sep 2023 10-Q 09 Nov 2023 2023 Q3
Q2 2023 $2,448,000 -$18,590,000 -88% 30 Jun 2023 10-Q 08 Aug 2023 2023 Q2
Q1 2023 $2,787,000 -$153,160,000 -98% 31 Mar 2023 10-Q 11 May 2023 2023 Q1
Q4 2022 $2,543,000 -$133,472,000 -98% 31 Dec 2022 10-K 19 Mar 2024 2023 FY
Q3 2022 $6,896,000 -$8,952,000 -56% 30 Sep 2022 10-Q 09 Nov 2022 2022 Q3
Q2 2022 $21,038,000 +$1,068,000 +5.3% 30 Jun 2022 10-Q 08 Aug 2022 2022 Q2
Q1 2022 $155,947,000 +$117,353,000 +304% 31 Mar 2022 10-Q 10 May 2022 2022 Q1
Q4 2021 $136,015,000 +$74,869,000 +122% 31 Dec 2021 10-K 01 Mar 2023 2022 FY
Q3 2021 $15,848,000 30 Sep 2021 10-Q 12 Nov 2021 2021 Q3
Q2 2021 $19,970,000 30 Jun 2021 10-Q 12 Aug 2021 2021 Q2
Q1 2021 $38,594,000 31 Mar 2021 10-Q 14 May 2021 2021 Q1
Q4 2020 $61,146,000 31 Dec 2020 10-K 01 Mar 2022 2021 FY
Q4 2017 $104,280,000 -$86,558,000 -45% 31 Dec 2017 10-K 12 Mar 2018 2017 FY
Q3 2017 $131,347,000 -$46,505,000 -26% 30 Sep 2017 10-Q 07 Nov 2017 2017 Q3
Q2 2017 $136,466,000 -$39,074,000 -22% 30 Jun 2017 10-Q 07 Aug 2017 2017 Q2
Q1 2017 $177,374,000 +$18,865,000 +12% 31 Mar 2017 10-Q 08 May 2017 2017 Q1
Q4 2016 $190,838,000 +$72,528,000 +61% 31 Dec 2016 10-K 12 Mar 2018 2017 FY
Q3 2016 $177,852,000 30 Sep 2016 10-Q 10 Nov 2016 2016 Q3
Q2 2016 $175,540,000 30 Jun 2016 10-Q 15 Aug 2016 2016 Q2
Q1 2016 $158,509,000 31 Mar 2016 10-Q 16 May 2016 2016 Q1
Q4 2015 $118,310,000 31 Dec 2015 10-K 15 Mar 2017 2016 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.